196
Participants
Start Date
December 1, 2015
Primary Completion Date
August 30, 2024
Study Completion Date
December 31, 2025
CAR T-cell therapy
Patients enrolled will receive infusion of CD19-targeting CAR T-cells with a target dose of 5\~10×10E6/kg of recipient weight, after the preparative regimen consisted of fludarabin (30mg/m2, day -5 to -3) and cyclophosphamide (300mg/m2, day -5 to -3).
The Fisrt Affiliated Hospital of Soochow University, Suzhou
Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd
INDUSTRY
The Second People's Hospital of Huai'an
OTHER
Third Military Medical University
OTHER
The First Affiliated Hospital of Soochow University
OTHER